NASH Screening in Diabetes
Hear Brent A. Neuschwander-Tetri, MD, explore NASH screening and the interplay among NAFLD, metabolic syndrome, CV risk, and diabetes risk, including: Should We Screen for NASH?Role of obesity and type 2 diabetes mellitus Cardiovascular Risk in NAFLD/NASH How to Evaluate for NAFLD/NASH Biomarkers Imaging When/whom to biopsy? Management in Multidisciplinary Settings Download the slides from this podcast at:https://bit.ly/2ZBvVvy See more NASH topics at:https://bit.ly/3ezkBq6